Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
NCT04011566 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-05-19
Summary
The purpose of the study is to determine if the ShuntCheck test can correctly identify flow or no flow in a ventriculoperitoneal shunt in patients with asymptomatic normal pressure hydrocephalus.
Conditions
- Hydrocephalus, Normal Pressure
Interventions
- DIAGNOSTIC_TEST
-
ShuntCheck
The intervention is an FDA-cleared device utilizing a transcutaneous thermal convection to analyze shunt flow.
Sponsors & Collaborators
-
NeuroDx Development
collaborator INDUSTRY -
University of South Florida
lead OTHER
Principal Investigators
-
Naomi Abel, MD · University of South Florida
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-11
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
Countries
- United States
Study Locations
More Related Trials
-
Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus
NCT00613886 ·Status: TERMINATED ·Phase: NA
-
Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
NCT06086561 ·Status: RECRUITING ·Phase: NA
-
Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices
NCT06513572 ·Status: TERMINATED
-
Role of Brain Specific Biomarkers in Hydrocephalus
NCT06083233 ·Status: COMPLETED
-
Normal Pressure Hydrocephalus (NPH) Registry
NCT00233701 ·Status: COMPLETED
-
A Trial of High and Low Pressure Level Settings on a Programmable Ventriculoperitoneal Shunt Valve for Idiopathic Normal Pressure Hydrocephalus
NCT01570257 ·Status: COMPLETED ·Phase: NA
-
Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device
NCT06506045 ·Status: TERMINATED
-
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
NCT05344599 ·Status: ACTIVE_NOT_RECRUITING
-
Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus
NCT05501002 ·Status: TERMINATED ·Phase: NA
-
Acetazolamide Trial in Normal Pressure Hydrocephalus
NCT04975269 ·Status: COMPLETED ·Phase: PHASE2
-
Anterior Pituitary Function in Patients With Hydrocephalus
NCT00149721 ·Status: TERMINATED ·Phase: NA
-
European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus
NCT00874198 ·Status: UNKNOWN ·Phase: NA
-
Normal Pressure Hydrocephalus Biomarkers Investigation
NCT05562596 ·Status: UNKNOWN
-
The Role of the Glymphatic System Avaluated Thourgh mr Imaging in the Diagnosis and Management of NPH
NCT06857136 ·Status: COMPLETED
-
Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus
NCT00600795 ·Status: COMPLETED
-
Subclassification of the Syndrome of Inappropriate ADH Secretion
NCT01341665 ·Status: COMPLETED
-
Acetazolamide for Treating NPH in Shunt-candidates Patients
NCT03779594 ·Status: UNKNOWN ·Phase: PHASE2
-
European Study of Prodromal iNPH
NCT05910944 ·Status: RECRUITING
-
Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
NCT00001453 ·Status: COMPLETED
-
Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester
NCT01201486 ·Status: COMPLETED
-
Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine
NCT00298753 ·Status: WITHDRAWN ·Phase: PHASE4
-
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
NCT05546996 ·Status: RECRUITING ·Phase: NA
-
Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
NCT01764711 ·Status: COMPLETED ·Phase: NA
-
Cerebral Blood Flow in Single Ventricles Throughout Staged Surgical Reconstruction
NCT02135081 ·Status: COMPLETED
-
Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
NCT01617616 ·Status: COMPLETED